Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 79.64313237090194 USD Million |
| 2019 | 82.3072298140209 USD Million |
| 2020 | 85.22668989425097 USD Million |
| 2021 | 88.42885553254071 USD Million |
| 2022 | 92.14756906366188 USD Million |
| 2023 | 96.24102694904552 USD Million |
| 2024 | 100.75366859624152 USD Million |
| 2025 | 105.73648209213664 USD Million |
| 2026 | 111.2481297391386 USD Million |
| 2027 | 117.3562942123456 USD Million |
| 2028 | 126.01381119018782 USD Million |
| 2029 | 135.69735532713565 USD Million |
| 2030 | 140.96553386676638 USD Million |
| 2031 | 151.79770558922542 USD Million |
| 2032 | 163.4622505947576 USD Million |
Data Source: Wantstats Repository
Market Dynamics
China is one of the major players in the Dry Eye Syndrome market. With the world’s largest population, there has been a significant growth in the occurrence of the condition in recent years and there is a huge demand for therapeutic treatments among Chinese individuals. In China, the older population is more likely to suffer from Dry Eye Syndrome than those in the younger age group, as age is a major factor in developing the condition. As the elderly population continues to grow with the increased life expectancy of Chinese citizens, the prevalence of this disorder is likely to grow too. Refractive errors, including myopia, also appear to be a contributing factor in the development of this condition in China, with myopia being especially prevalent in East Asian countries. Furthermore, a number of lifestyle factors such as computer use, smoking and sun exposure can all lead to dry eyes. As the working environment evolves to become ever more digital, these types of lifestyle practices are on the rise, and therefore so is the number of cases of Dry Eye Syndrome.
The Chinese government has been actively investing in the development of therapeutics and services for Dry Eye Syndrome since 2016, encouraging companies to develop innovative treatments for this condition. This has led to a number of approved treatments now available in China, and the prevalence of Dry Eye Syndrome has been largely stabilised as a result. However, the large number of cases of Dry Eye Syndrome, coupled with the population size, means that demand for treatments is likely to remain high. This means that, even as treatment is made more readily available to those in need, the Chinese Dry Eye Syndrome market will remain robust in the foreseeable future. As novel therapeutics, services, and technologies are developed and licensed in China, the Dry Eye Syndrome market is likely to grow even further. There is also potential for new products and treatments to be developed in response to the specific Chinese patient population, in order to meet their needs, preferences and cultural background. With the continued development and licensure of innovative new therapies, the Chinese Dry Eye Syndrome market is likely to maintain positive growth over the next decade.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



